309 related articles for article (PubMed ID: 36361933)
1. Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.
Tobacman JK; Bhattacharyya S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361933
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
[TBL] [Abstract][Full Text] [Related]
3. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
Kotlo K; Bhattacharyya S; Yang B; Feferman L; Tejaskumar S; Linhardt R; Danziger R; Tobacman JK
Glycoconj J; 2013 Oct; 30(7):667-76. PubMed ID: 23385884
[TBL] [Abstract][Full Text] [Related]
4. Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice.
Bhattacharyya S; Tobacman JK
J Alzheimers Dis Rep; 2023; 7(1):527-534. PubMed ID: 37313486
[TBL] [Abstract][Full Text] [Related]
5. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
Bhattacharyya S; Feferman L; Terai K; Dudek AZ; Tobacman JK
Oncotarget; 2017 Jan; 8(3):4169-4180. PubMed ID: 27926479
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.
Bhattacharyya S; Tobacman JK
PLoS One; 2012; 7(3):e33250. PubMed ID: 22428001
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.
Bhattacharyya S; Feferman L; Tobacman JK
PLoS One; 2016; 11(4):e0153463. PubMed ID: 27078017
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates.
Bhattacharyya S; Kotlo K; Shukla S; Danziger RS; Tobacman JK
J Biol Chem; 2008 Apr; 283(15):9523-30. PubMed ID: 18285341
[TBL] [Abstract][Full Text] [Related]
9. Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice.
Bhattacharyya S; Tobacman JK
bioRxiv; 2023 Apr; ():. PubMed ID: 37066366
[TBL] [Abstract][Full Text] [Related]
10. Does deficiency of arylsulfatase B have a role in cystic fibrosis?
Tobacman JK
Chest; 2003 Jun; 123(6):2130-9. PubMed ID: 12796199
[TBL] [Abstract][Full Text] [Related]
11. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
Bhattacharyya S; O-Sullivan I; Tu J; Chen Z; Tobacman JK
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166913. PubMed ID: 37813168
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.
Bhattacharyya S; Tobacman JK
J Nutr Biochem; 2012 Sep; 23(9):1058-63. PubMed ID: 22079206
[TBL] [Abstract][Full Text] [Related]
13. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.
Bradford TM; Litjens T; Parkinson EJ; Hopwood JJ; Brooks DA
Biochemistry; 2002 Apr; 41(15):4962-71. PubMed ID: 11939792
[TBL] [Abstract][Full Text] [Related]
14. Mucopolysaccharidosis Type VI, an Updated Overview of the Disease.
D'Avanzo F; Zanetti A; De Filippis C; Tomanin R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948256
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
Bhattacharyya S; Feferman L; Tobacman JK
J Biol Chem; 2014 Jun; 289(25):17564-75. PubMed ID: 24778176
[TBL] [Abstract][Full Text] [Related]
16. Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect.
Bhattacharyya S; Feferman L; Tobacman JK
Sci Rep; 2016 Sep; 6():32885. PubMed ID: 27605497
[TBL] [Abstract][Full Text] [Related]
17. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
Bhattacharyya S; Feferman L; Tobacman JK
Biochim Biophys Acta; 2015 Mar; 1849(3):342-52. PubMed ID: 25511584
[TBL] [Abstract][Full Text] [Related]
18. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK
J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138
[TBL] [Abstract][Full Text] [Related]
19. Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells.
Bhattacharyya S; Feferman L; Tobacman JK
Pulm Pharmacol Ther; 2016 Feb; 36():22-30. PubMed ID: 26656789
[TBL] [Abstract][Full Text] [Related]
20. Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene.
Garrido E; Cormand B; Hopwood JJ; Chabás A; Grinberg D; Vilageliu L
Mol Genet Metab; 2008 Jul; 94(3):305-12. PubMed ID: 18406185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
